1. Home
  2. MBIN vs NVCR Comparison

MBIN vs NVCR Comparison

Compare MBIN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBIN

Merchants Bancorp

HOLD

Current Price

$34.94

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.67

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIN
NVCR
Founded
1990
2000
Country
United States
Switzerland
Employees
663
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
MBIN
NVCR
Price
$34.94
$12.67
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$39.67
$26.42
AVG Volume (30 Days)
136.2K
1.1M
Earning Date
01-28-2026
02-26-2026
Dividend Yield
1.13%
N/A
EPS Growth
N/A
N/A
EPS
4.34
N/A
Revenue
$597,247,000.00
$642,269,000.00
Revenue This Year
$5.17
$9.68
Revenue Next Year
$7.24
$6.03
P/E Ratio
$8.13
N/A
Revenue Growth
N/A
11.17
52 Week Low
$27.25
$10.70
52 Week High
$43.82
$26.47

Technical Indicators

Market Signals
Indicator
MBIN
NVCR
Relative Strength Index (RSI) 50.54 42.26
Support Level $34.51 $12.80
Resistance Level $36.82 $14.29
Average True Range (ATR) 0.97 0.65
MACD -0.05 -0.17
Stochastic Oscillator 28.77 1.20

Price Performance

Historical Comparison
MBIN
NVCR

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: